PlainPharmaWatch

CMS Open Payments · Program Year 2024

Actelion Pharmaceuticals, Ltd

Actelion Pharmaceuticals, Ltd reported $103,191.32 in payments to 55 physicians and teaching hospitals across 55 transactions.

See the rankings → How this is sourced
$103.2K
Total payments
55
Transactions
55
Recipients
+$1.8K
General Payments vs PY2023

Actelion Pharmaceuticals, Ltd reported $103,191.32 in payments to 55 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1177 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.9K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Actelion Pharmaceuticals, Ltd pairs below-median payment volume with a moderately concentrated payment pattern.

#1177
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Actelion Pharmaceuticals, Ltd's CMS-reported General Payments increased by $1.8K (+1.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ACTELION PHARMACEUTICALS, LTDPY2023: ACTELION PHARMACEUTICALS, LTDPY2024: Actelion Pharmaceuticals, Ltd. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$101.4KPY2024$103.2K
PY2023
$101,355.26
PY2024
$103,191.32

How Actelion Pharmaceuticals, Ltd ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Actelion Pharmaceuticals, Ltd's total vs. every reporting company

CMS Open Payments, Program Year 2024

$103,191 39th percentile higher than 39% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Actelion Pharmaceuticals, Ltd

Averaging $1.9K per transaction and $1.9K per recipient, Actelion Pharmaceuticals, Ltd's Program Year 2024 total comes to $103,191.32 across 55 transactions and 55 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1177 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $50.8K, accounting for 49.2% of the company's reported total and 23 transactions.

General Payment Breakdown by Type

Actelion Pharmaceuticals, Ltd made 4 types of general payments. "Travel and Lodging" is the largest category at $50.8K, 49.2% of the company's reported total.

How Actelion Pharmaceuticals, Ltd divides its payments

Top payment categories by total reported dollar volume

1. Travel and Lodging$50.8K2. Consulting Fee$50.7K3. Food and Beverage$1.4K4. Compensation for Services…$347.00
Payment Type Amount Transactions
Travel and Lodging $50.8K 23
Consulting Fee $50.7K 12
Food and Beverage $1.4K 19
Compensation for Services Other Than Consulting $347.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $103,191.32 (100.0%) of $103,191.32 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Actelion Pharmaceuticals, Ltd

The five named recipients with the highest reported General Payments from this company

Hyong S Kim$32.1KVallerie V Mclaughlin$25.9KJean Marie Elwing$16.1KIoana R Preston$15.9KMelisa Wilson$13.2K
  1. 1

    Hyong S Kim

    $32,086.78 across 16 reported transactions

  2. 2

    Vallerie V Mclaughlin

    $25,875.05 across 11 reported transactions

  3. 3

    Jean Marie Elwing

    $16,090.11 across 10 reported transactions

  4. 4

    Ioana R Preston

    $15,923.88 across 10 reported transactions

  5. 5

    Melisa Wilson

    $13,215.50 across 8 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.9K. Average per recipient: $1.9K.

Total Amount

$103,191.32

Avg per Transaction

$1.9K

Avg per Recipient

$1.9K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Actelion Pharmaceuticals, Ltd Share

0.0%

#1177 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Actelion Pharmaceuticals, Ltd

Halozyme Inc

$103.3K 326 recipients

Think Surgical, Inc.

$103.4K 207 recipients

HMU Consumables, LLC

$103.7K 0 recipients

OrthoPediatrics Canada ULC

$104.0K 5 recipients

Kowa Pharmaceuticals America, Inc.

$101.9K 5,883 recipients

BioPro, Inc.

$101.9K 145 recipients

Frequently Asked Questions

How much did Actelion Pharmaceuticals, Ltd pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $103,191.32 from Actelion Pharmaceuticals, Ltd to physicians and hospitals across 55 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Actelion Pharmaceuticals, Ltd? ▾
Actelion Pharmaceuticals, Ltd made payments to 55 physicians and teaching hospitals in 2024. The average payment per recipient was $1.9K.
What types of payments did Actelion Pharmaceuticals, Ltd make? ▾
4 categories of general payment make up Actelion Pharmaceuticals, Ltd's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Travel and Lodging" at $50.8K, representing 49.2% of the company's reported total.
How does Actelion Pharmaceuticals, Ltd rank among pharmaceutical companies? ▾
By total payment amount, Actelion Pharmaceuticals, Ltd sits at #1177 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Actelion Pharmaceuticals, Ltd? ▾
The average transaction from Actelion Pharmaceuticals, Ltd was $1.9K in 2024. The company made 55 total transactions to 55 recipients.
Where does the payment data for Actelion Pharmaceuticals, Ltd come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Actelion Pharmaceuticals, Ltd's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.